Ledger.Open graph →
SEC Form D · Amendment · filed November 10, 2022

Paragon Biosciences Emalex Capital, Inc

Offering
$250.0M
Sold
$185.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORTHBROOK, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Patrick J. Morris · Chicago, ILExec · DirectorAntonio J. Gracias · Chicago, ILDirectorJeffrey J. Aronin · Chicago, ILExec · DirectorDarien J. Parhad · Chicago, ILExecWilliam D. Rahm · New York, NYExec · DirectorRicardo Lombardi · New York, NYDirectorAmit Assaraf · New York, NYExecPatrick N. Nolan · Atlanta, GAExec · DirectorKevin Chavers · New York, NYDirectorAl C. Laskaj · NEW YORK, NYExec · DirectorDana C. Devivo · NEW YORK, NYExecFrancis C. Poli · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗